Skip to main content
All lobbying filings

RAI SERVICES COMPANY

Lobbying for RAI SERVICES COMPANY

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$2,000,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbying activity 6

Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA, PMTA, and MRTP compliance policies Issues surrounding tobacco harm reduction Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes Issues surrounding FDA/CTP enforcement actions Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes January 2025 Proposed Rule: Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products Docket No. FDA-2026-D-1817 (91 Fed. Reg. 11,980, Mar. 11, 2026) - Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications- Considerations Related to Youth Risk FDA Guidance: Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization (May 12, 2026) Discussions regarding federal excise taxes and the taxation of tobacco products. Discussions regarding FDA enforcement of flavored disposable e-cigarettes and PMTA transparency

Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs)

H.R. 8646/S. ____, Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027, including provisions related to trade and the FDA regulation of tobacco

Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis

Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis

S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products

 Bills named in this filing 4
  • H.R. 8646
    Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
  • S. 464
    No Tax Subsidies for E-Cigarette and Tobacco Ads Act
  • S. 2929
    Tobacco Tax Equity Act of 2023
  • H.R. 5715
    Tobacco Tax Equity Act of 2023

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem